Add to ORKGnone12noneRiccardo Schiavina; Valerio Vagnoni; Marco Borghesi; Eugenio Brunocilla; Hussam Dababneh; Daniele Romagnoli; Cristian V. Pultrone; Giacomo Saraceni; Francesco Mengoni; Giovanni Passaretti; Davide Diazzi; Giuseppe MartoranaRiccardo Schiavina; Valerio Vagnoni; Marco Borghesi; Eugenio Brunocilla; Hussam Dababneh; Daniele Romagnoli; Cristian V. Pultrone; Giacomo Saraceni; Francesco Mengoni; Giovanni Passaretti; Davide Diazzi; Giuseppe Martoran
Lymph node (LN) metastasis is considered an important prognostic factor in patients with prostate ca...
PURPOSE: To evaluate the utilization of pelvic lymph node dissection (PLND) and its extent in contem...
Background: Previous trials have shown that the number of procedures done by a single surgeon, that ...
Objective: The aim of this study was to compare the predictive ability of lymph node density (LND) a...
none10noneRiccardo Schiavina; Marco Borghesi; Eugenio Brunocilla; Valerio Vagnoni; Cristian Pultrone...
To assess whether any relationship exists between the number of histologically examined lymph nodes ...
Background. To evaluate the prognostic role of lymph node density (LND) in patients affected by pro...
none11siOBJECTIVES: To evaluate the outcomes in patients with node-positive prostate cancer (PCa) af...
BACKGROUND: The therapeutic role of pelvic lymph-node dissection (PLND) for prostate cancer (PCa) is...
BACKGROUND: Conflicting results exist regarding the value of an extended pelvic lymph node dissectio...
Background: The role of extended pelvic lymph node dissection (ePLND) in treating prostate cancer (P...
PURPOSE: To investigate the pattern of lymph node spread in prostate cancer patients with a biochemi...
Background: Few predictive models aimed at predicting the presence of lymph node invasion (LNI) in p...
Purpose: Pelvic lymph node dissection represents the gold standard of lymph node staging in patients...
none29noneSchiavina Riccardo; Martorana Giuseppe; Brunocilla Eugenio; Borghesi Marco; Gacci Mauro; C...
Lymph node (LN) metastasis is considered an important prognostic factor in patients with prostate ca...
PURPOSE: To evaluate the utilization of pelvic lymph node dissection (PLND) and its extent in contem...
Background: Previous trials have shown that the number of procedures done by a single surgeon, that ...
Objective: The aim of this study was to compare the predictive ability of lymph node density (LND) a...
none10noneRiccardo Schiavina; Marco Borghesi; Eugenio Brunocilla; Valerio Vagnoni; Cristian Pultrone...
To assess whether any relationship exists between the number of histologically examined lymph nodes ...
Background. To evaluate the prognostic role of lymph node density (LND) in patients affected by pro...
none11siOBJECTIVES: To evaluate the outcomes in patients with node-positive prostate cancer (PCa) af...
BACKGROUND: The therapeutic role of pelvic lymph-node dissection (PLND) for prostate cancer (PCa) is...
BACKGROUND: Conflicting results exist regarding the value of an extended pelvic lymph node dissectio...
Background: The role of extended pelvic lymph node dissection (ePLND) in treating prostate cancer (P...
PURPOSE: To investigate the pattern of lymph node spread in prostate cancer patients with a biochemi...
Background: Few predictive models aimed at predicting the presence of lymph node invasion (LNI) in p...
Purpose: Pelvic lymph node dissection represents the gold standard of lymph node staging in patients...
none29noneSchiavina Riccardo; Martorana Giuseppe; Brunocilla Eugenio; Borghesi Marco; Gacci Mauro; C...
Lymph node (LN) metastasis is considered an important prognostic factor in patients with prostate ca...
PURPOSE: To evaluate the utilization of pelvic lymph node dissection (PLND) and its extent in contem...
Background: Previous trials have shown that the number of procedures done by a single surgeon, that ...